Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications.

Journal of Hepatology
J U MarquardtSnorri S Thorgeirsson

Abstract

The two dominant models of carcinogenesis postulate stochastic (clonal evolution) or hierarchic organization of tumor (cancer stem cell model). According to the latter, at the germinal center of tumor evolution is a cancer stem cell (CSC) which, similar to normal adult stem cells, possesses the capacity of self-renewal and a differentiation potential. Over the past few years, compelling evidence has emerged in support of the hierarchic cancer model for many solid tumors including hepatocellular cancers. The CSCs are posited to be responsible not only for tumor initiation but also for the generation of distant metastasis and relapse after therapy. These characteristics are particularly relevant for a multi-resistant tumor entity like human hepatocellular carcinoma and may herald a paradigm shift in the management of this deadly disease. Identification and detailed characterization of liver CSCs is therefore imperative for improving prevention approaches, enhancing early detection, and extending the limited treatment options. Despite the current progress in understanding the contribution of CSCs to the generation of heterogeneity of tumors, the molecular complexity and exact regulation of CSCs is poorly understood. This review fo...Continue Reading

References

Jul 29, 1977·Science·A W Hamburger, S E Salmon
Oct 1, 1976·Science·P C Nowell
Feb 1, 1986·Medical Hypotheses·G Zajicek
Apr 1, 1996·The Journal of Experimental Medicine·M A GoodellR C Mulligan
Jul 23, 2002·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Andy J G PötgensHans-Georg Frank
Nov 6, 2002·Clinica Chimica Acta; International Journal of Clinical Chemistry·Frederick L Kiechle, Xinbo Zhang
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Sep 26, 2003·The American Journal of Pathology·Sun LeeGyeong Hoon Kang
Jan 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Toru KondoTetsuya Taga
Jan 21, 2004·Nature Reviews. Cancer·Andrew P Feinberg, Benjamin Tycko
Aug 19, 2004·Cell·Merel E Valk-LingbeekMaarten van Lohuizen
Sep 7, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ju-Seog LeeSnorri S Thorgeirsson
Sep 28, 2004·Nature Genetics·Eran SegalAviv Regev
Apr 2, 2005·Nature Reviews. Cancer·Michael DeanSusan Bates
May 27, 2005·Seminars in Liver Disease·Ju-Seog Lee, Snorri S Thorgeirsson
May 27, 2005·Seminars in Liver Disease·Josep M LlovetVincenzo Mazzaferro
Oct 8, 2005·Science·Lopa MishraBibhuti Mishra
Dec 22, 2005·Nature Reviews. Genetics·Andrew P FeinbergSteven Henikoff
Feb 17, 2006·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Eric Santoni-RugiuHanne Cathrine Bisgaard
Feb 21, 2006·Cancer Research·Richard P Hill
May 3, 2006·Cancer Research·Linheng Li, William B Neaves
May 10, 2006·Investigational New Drugs·Nico JanssensTim Perera
Jun 27, 2006·Oncogene·J-S Lee, S S Thorgeirsson
Jun 27, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tetsuhiro ChibaHideki Taniguchi
Jul 20, 2006·Current Cancer Drug Targets·L MieleB J Nickoloff
Aug 25, 2006·Nature Reviews. Cancer·Paraskevi A Farazi, Ronald A DePinho
Nov 14, 2006·Biochemical and Biophysical Research Communications·Atsushi SuetsuguHisataka Moriwaki
Dec 2, 2006·Nature Reviews. Drug Discovery·Nick Barker, Hans Clevers
Dec 5, 2006·Stem Cell Reviews·Malcolm R Alison
Dec 26, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sandrine BoyaultJessica Zucman-Rossi
Jan 4, 2007·Nature Genetics·Martin WidschwendterPeter W Laird
Jan 19, 2007·The New England Journal of Medicine·Rui LiuMichael F Clarke
Feb 7, 2007·Cancer Research·Chenwei LiDiane M Simeone
Feb 14, 2007·Seminars in Liver Disease·Augusto VillanuevaJosep M Llovet
Apr 6, 2007·Endocrine Reviews·Victoria BolósJosé Luis de la Pompa
Jun 16, 2007·Gastroenterology·Stephanie MaXin-Yuan Guan
Aug 25, 2007·The Journal of Clinical Investigation·Diego F CalvisiSnorri S Thorgeirsson

❮ Previous
Next ❯

Citations

Dec 29, 2010·Journal of Oncology·Fatima RangwalaAnna Mae Diehl
Oct 14, 2011·International Journal of Hepatology·Sameh Mikhail, Aiwu Ruth He
Nov 20, 2015·Journal of Pathology and Translational Medicine·Jong Jin SungWoo Sung Moon
Jun 29, 2013·Clinics and Research in Hepatology and Gastroenterology·Chiara Raggi, Pietro Invernizzi
May 13, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sheng-xian YuanWei-ping Zhou
May 26, 2011·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Eric L SceusiCurtis J Wray
Jun 22, 2011·Clinics in Liver Disease·Nedim Hadzic, Milton J Finegold
Jul 3, 2015·Biological & Pharmaceutical Bulletin·Kyung-Ju ChoiYun-Han Lee
Nov 24, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tsunekazu OikawaHiromitsu Nakauchi
Oct 28, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C Bart RountreeHolger Willenbring
Aug 22, 2012·Journal of Hepato-biliary-pancreatic Sciences·Toshio KokuryoMasato Nagino
Aug 18, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kun WuHong-Yang Wang
Jul 24, 2014·International Journal of Cancer. Journal International Du Cancer·Joan FernandoIsabel Fabregat
May 6, 2015·Journal of Hepatology·Jens U MarquardtSnorri S Thorgeirsson
Apr 30, 2015·Clinics in Liver Disease·Olivier Govaere, Tania Roskams
Sep 24, 2016·Neoplasia : an International Journal for Oncology Research·Eunsohl LeeRussell S Taichman
Mar 5, 2016·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Rujuan SuKejun Nan
Jun 12, 2013·Biology·Jens U Marquardt, Jesper B Andersen
Nov 27, 2014·World Journal of Stem Cells·Lei-Bo Xu, Chao Liu
Jan 20, 2015·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Ijin JooJeong Min Lee
May 31, 2016·F1000Research·Renumathy DhanasekaranLewis R Roberts
Sep 21, 2012·International Journal of Oncology·Jun Sang BaeWoo Sung Moon
Sep 16, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Oriana Lo ReManlio Vinciguerra
Oct 28, 2017·Cancer Cell International·Takehiro HayashiShuichi Kaneko
Feb 8, 2013·The American Journal of Surgical Pathology·Jun AkibaHirohisa Yano
Jan 23, 2018·Journal of Neuro-oncology·Yung-Chiang LiuPin-Yuan Chen
Oct 4, 2018·Viruses·Alessia VirzìJoachim Lupberger
Jan 10, 2019·Therapeutic Advances in Medical Oncology·Nuozhou WangGeorge G Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Related Papers

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Anuradha BudhuXin Wei Wang
International Journal of Hepatology
Sameh Mikhail, Aiwu Ruth He
© 2021 Meta ULC. All rights reserved